FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

FBI and Texas authorities arrest 276 suspected child predators, rescue 89 children in sweeping operation

Federal Judge Blocks Trump’s $1.8 Billion ‘Anti-Weaponization Fund,’ Setting Up Critical Hearing

‘There Are No Words’: 6th Grader Dies on School Trip

Federal judge orders Trump’s name removed from Kennedy Center, says only Congress can rename it

Spanberger ripped over ignored ICE detainer after illegal alien with 18 prior charges accused of sex assault

House Republican Don Bacon says he wants ‘pariah state’ Russia booted from UN Security Council

Louisiana passes new congressional map

Pope Leo meets with Chicago’s far-left mayor, George Floyd’s family lawyer at the Vatican

Democrats eye Blanche and Patel subpoenas after Bondi deflects Epstein questions

Anti-ICE agitator screams ‘I’ll kill your whole f- family’ day after Dem gov praises ‘peaceful protesting’

‘Divisive’: Martina McBride Pulls Out of America 250 Birthday Concert Over Politics

Not Satire: Newsom Took Money That Could Have Helped Stop Palisades Fires and Spent It Teaching American Indians to Start Fires

Former Russian president warns Europe’s ‘peaceful sleep is over’ after Romania drone hit

Kevin Kiley’s two-front fight: Battling California redistricting while defending his own seat

Dead voter allegation fuels concerns about voting safeguards as blue state official turns herself in

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”